A Non-Cross-Linking Platinum−Acridine Agent with Potent Activity in Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A Non-Cross-Linking Platinum−Acridine Agent with Potent Activity in Non-Small-Cell Lung Cancer

Published:2008-11-14 Issue:23 Volume:51 Page:7574-7580
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ma Zhidong¹,Choudhury Jayati Roy¹,Wright Marcus W.¹,Day Cynthia S.¹,Saluta Gilda¹,Kucera Gregory L.¹,Bierbach Ulrich¹

Affiliation:

1. Department of Chemistry, Wake Forest University, Winston-Salem, North Carolina 27109, Department of Internal Medicine, Hematology-Oncology Section, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, and Comprehensive Cancer Center of Wake Forest University, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm800900g

Reference33 articles.

1. The resurgence of platinum-based cancer chemotherapy

2. Molecular mechanisms of resistance and toxicity associated with platinating agents

3. Platinum drugs in the treatment of non-small-cell lung cancer

4. Optimal Adjuvant Therapy for Non-Small Cell Lung Cancer—How to Handle Stage I Disease

5. Is cisplatin still the best platinum compound in non-small-cell lung cancer?

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead;ChemMedChem;2024-07-05

2. The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone;International Journal of Molecular Sciences;2024-06-13

3. Synthetic routes and chemical structural analysis for guiding the strategies on new Pt(ii) metallodrug design;Dalton Transactions;2024

4. Potential of covalently linked tamoxifen hybrids for cancer treatment: recent update;RSC Medicinal Chemistry;2024

5. Development of Prodrug–Payloads for Targeted Therapeutic Applications of Platinum–Acridine Anticancer Agents;Bioconjugate Chemistry;2023-10-09